Coley Pharmaceutical GmbH
Records under this name other than the patents Coley Pharmaceutical GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Coley Pharmaceutical GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,354,522 | Immunostimulatory oligoribonucleotides Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,153,141 | Immunostimulatory G, U-containing oligoribonucleotides Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,382,545 | CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,260,071 | CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,662,949 | Immunostimulatory oligoribonucleotides Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,227,447 | RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,466,124 | RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,128,944 | RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,453,059 | Immunostimulatory Oligonucleotides No holder on record In force · High confidence | In force | High confidence | |
| US 8,580,268 | CPG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity Formerly held In force · High confidence | In force | High confidence |